Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study

Miriam Nickel, Alessandro Simonati, David Jacoby, Susanne Lezius, Dirk Kilian, Benjamin Van de Graaf, Odelya E Pagovich, Barry Kosofsky, Kaleb Yohay, Matthew Downs, Peter Slasor, Temitayo Ajayi, Ronald G Crystal, Alfried Kohlschütter, Dolan Sondhi, Angela Schulz

Open source

DOI: 10.1016/s2352-4642(18)30179-2
Published: 2018-08
Container: The Lancet Child & Adolescent Health
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s2352-4642-18-30179-2,
  title = {Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study},
  author = {Miriam Nickel and Alessandro Simonati and David Jacoby and Susanne Lezius and Dirk Kilian and Benjamin Van de Graaf and Odelya E Pagovich and Barry Kosofsky and Kaleb Yohay and Matthew Downs and Peter Slasor and Temitayo Ajayi and Ronald G Crystal and Alfried Kohlschütter and Dolan Sondhi and Angela Schulz},
  year = {2018},
  journal = {The Lancet Child \&amp; Adolescent Health},
  doi = {10.1016/s2352-4642(18)30179-2},
  url = {https://doi.org/10.1016/s2352-4642(18)30179-2}
}

RIS

TY  - JOUR
TI  - Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
AU  - Miriam Nickel
AU  - Alessandro Simonati
AU  - David Jacoby
AU  - Susanne Lezius
AU  - Dirk Kilian
AU  - Benjamin Van de Graaf
AU  - Odelya E Pagovich
AU  - Barry Kosofsky
AU  - Kaleb Yohay
AU  - Matthew Downs
AU  - Peter Slasor
AU  - Temitayo Ajayi
AU  - Ronald G Crystal
AU  - Alfried Kohlschütter
AU  - Dolan Sondhi
AU  - Angela Schulz
PY  - 2018
JO  - The Lancet Child &amp; Adolescent Health
DO  - 10.1016/s2352-4642(18)30179-2
UR  - https://doi.org/10.1016/s2352-4642(18)30179-2
ER  -

APA

Nickel, M., Simonati, A., Jacoby, D., Lezius, S., Kilian, D., Graaf, B. V. D., Pagovich, O. E., Kosofsky, B., Yohay, K., Downs, M., Slasor, P., Ajayi, T., Crystal, R. G., Kohlschütter, A., Sondhi, D., & Schulz, A. (2018). Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. The Lancet Child & Adolescent Health. https://doi.org/10.1016/s2352-4642(18)30179-2

Source records

crossref · retrieved 2026-09-26T04:44:10.042Z